Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Study of Adjuvant ONO-4538 With Resected Gastric Cancer [Phase 3]
Phase 3 trial evaluating adjuvant ONO-4538 (nivolumab) after gastric cancer resection has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer [Phase 3]
Phase 3 clinical trial update reporting completion of the study evaluating ONO-4538 (nivolumab) in unresectable advanced or recurrent gastri…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Multicentric Randomised Trial for Resectable Gastric Cancer [Phase 2]
This entry reports a multicenter randomized Phase 2 trial for resectable gastric cancer, sponsored by The Netherlands Cancer Institute, curr…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration
This ClinicalTrials.gov entry describes a Zhejiang University study evaluating intelligent screening and decision-making for neoadjuvant the…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. [Phase 4]
A Phase 4 trial evaluating the effect of chemoradiotherapy on gastric perfusion in gastric cancer patients has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Model for Prognosis of Elderly Gastric Cancer Patients
This completed clinical trial investigates a prognostic model for predicting outcomes in elderly gastric cancer patients.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer [Phase 2, Phase 3]
A Phase 2/3 trial is evaluating whether adding tislelizumab with apatinib and oxaliplatin plus S-1 as neoadjuvant therapy improves outcomes …
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Development and Testing of a Social Cognitive Theory-based Dietary Behavioral Intervention in Gastric Cancer Survivors [NA]
A clinical trial update reports completion of development and testing of a Social Cognitive Theory-based dietary behavioral intervention for…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: PWP1's Expression in Gastric Cancer.
The document notes that a clinical trial evaluating PWP1 expression in gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy
A clinical trial comparing two esophagogastrostomy techniques (π-shaped vs overlap) during totally laparoscopic total gastrectomy for gastri…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: PRIORITY-CONNECT 2 Pilot Trial [NA]
The PRIORITY-CONNECT 2 Pilot Trial is currently recruiting. Sponsored by the Surgical Outcomes Research Centre, the study investigates liver…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of combining XELOX with sintilimab and lenvatinib in patients with advanced AFP-po…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China [NA]
A ClinicalTrials.gov study from Peking University in China is assessing whether financial incentives and motivational interventions can impr…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer [Phase 2]
Phase 2 trial evaluating durvalumab in combination with olaparib and paclitaxel for advanced gastric cancer; currently active but not recrui…
-
FDA approval · 2024-04-15FDA Approved: CAPECITABINE — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for Capecitabine, updating regulatory status for this cancer drug. The action lik…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating HLX22 combined with trastuzumab and chemotherapy versus placebo with trastuzumab and chemotherapy for loca…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Chemoprevention of Gastric Carcinogenesis [Phase 2]
A Phase 2 chemoprevention trial for gastric carcinogenesis has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy [Phase 2, Phase 3]
Phase 2/3 trial evaluating DV in combination with cadonilimab for HER2-expressing gastric cancer and gastroesophageal junction adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies [Phase 2]
Phase II study evaluating lenvatinib with pembrolizumab in metastatic gastroesophageal and gastric cancer after prior therapies; study compl…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC [Phase 2]
Phase 2 trial evaluating infusional fluorouracil plus weekly docetaxel in gastric cancer with bone marrow involvement and DIC; study complet…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Study of TAS-120 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of futibatinib (TAS-120) in patients with advanced solid tumors, including cholangiocarcinoma, urothelial carcinoma, breas…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) [Phase 2]
Phase 2 PROCEED trial evaluating pembrolizumab with radiotherapy and chemotherapy as neoadjuvant treatment for locally advanced esophageal a…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer [Phase 2]
Phase 2 trial update for KeyLargo combining pembrolizumab with oxaliplatin and capecitabine in gastric and esophageal cancer; study complete…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive [Phase 2]
Phase 2 clinical trial update investigating pembrolizumab with CapeOx in HER2-negative gastric cancer and pembrolizumab with trastuzumab and…